Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In 2023 ADA guidelines said that, alongside lower hypoglycemia and obesity, GLP-1 agonists are highly recommended drugs among patients with clinical ASCVD risks (eg, prior myocardial infarction, stroke), as they lower cardiovascular risk
Alcohol may worsen nausea, vomiting, reflux, dehydration, or blood-sugar problems for some patients
For individuals with metabolic conditions that make weight loss extremely difficult
Ovaries: GLP-1 reduces androgens, increases SHBG, improves PCOS morphology, and reduces ovarian inflammation
Covers Wegovy (oral $149/mo via Walgreens, injection $349/mo direct), Saxenda (limited), Ozempic and Rybelsus (savings card $25/mo for eligible commercial)
The direct answer is nuanced: weight loss injections do not appear to impair fertility and may actually improve fertility potential through metabolic improvements, but they require careful management in the preconception period
